Haixia Cui

Haixia Cui


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2022 in Medicine
Verified
Journal Article
Open access
HCHaixia Cui
Haixia Cui
YHYuan Huang
Yuan Huang
WWWei bo Wen
Wei bo Wen
XLXiangdan Li
Xiangdan Li
DXDongyuan Xu
Dongyuan Xu
LLLan Liu
Lan Liu
Background: The role of the lymph node ratio (LNR) in the existing tumor node metastasis classification system should be verified as one of the prognosis prediction factors. This work evaluated LNR’s performance in predicting cervical cancer (CC) prognosis through a meta-analysis. Method: Related studies were retrieved from the Cochrane Library, EMBASE, and PubMed databases. The language was restricted to English. The combined hazard ratios (HRs) were utilized to analyze the prognostic value of LNR. Results.: Our study included 8 articles with 3325 subjects published after 2015. Based on our analysis, high LNR was the adverse prognostic factor for overall survival (OS, HR = 1.45; 95% CI = 1.23–1.73; P = .238) and disease-free survival (DFS, HR = 2.69; 95% CI = 1.98–3.66; P = .597) among the CC cases. Furthermore, as revealed by subgroup analysis, in CC patients, median LNR of about 0.0625 and 0.066 served as the prominent risk factor for DFS and OS. Conclusions: The current work illustrates that elevated LNR is related to the dismal prognosis of CC. More well-designed clinical studies are warranted for assessing whether LNR is a factor independently predicting the prognosis of CC.

27 April 2026 in Neuropharmacology
Verified
Journal Article
Closed access
CHChao Huang
Chao Huang
XZXianjing Zhang
Xianjing Zhang
JYJingwei Yu
Jingwei Yu
CXChouhui Xuan
Chouhui Xuan
CXChunhua Xu
Chunhua Xu
DXDongyuan Xu
Dongyuan Xu